TLR9 and COVID-19: CpG-1018, a TLR9 agonist absorbed onto aluminum salt, is included in an FDA-approved HBV vaccine and has also been used in emergency use authorized (EUA) COVID-19 vaccines to boost immune responses against viral infections.